Magnolia Medical introduces new technology-enabled service for sepsis

Magnolia Medical has launched Magnolia Analytics, a technology-driven service aimed at enhancing data capture and evaluating the clinical and cost-effectiveness of interventions to prevent sepsis misdiagnosis. Developed in collaboration with US hospital systems, this end-to-end software solution supports hospitals in meeting new national standards for minimizing blood culture contamination.

The platform addresses the critical need for robust assessment of the clinical and economic benefits achieved through reduced blood culture contamination rates, aligning with recent CDC guidelines on accurate sepsis testing for hospital financial efficiency and patient safety.

According to Magnolia Medical, the adoption of their Steripath technology and Mission to ZERO program in nearly 500 US hospitals underscores the impact of their solutions. Magnolia Analytics now provides transparent performance monitoring, enabling hospital leadership to objectively evaluate the effectiveness of new devices and interventions at both facility and patient levels.